MAPT and tauopathy: Moreover, BT1-loaded NPM-HumAfFt was shown to be efficiently and selectively incorporated in human retinal cells and to bind tau fibrils with high affinity and selectivity, revealing its potential as a tool for the investigation of tauopathies.